Dr.Farah Sleiman

Dr. Farah Sleiman is a seasoned investment and growth adviser with nearly two decades of experience in the MENA and GCC region.

She possesses expert knowledge in management consulting, market research, business development, mergers and acquisitions, capital raising, and investors relations.

Her specialties include growth strategy, turnaround strategy, investment strategy, fundraising, operational planning, due diligence, product development, feasibility studies, business planning, mergers & acquisitions, market assessment, valuation, and executive coaching.

Dr. Sleiman has a deep expertise in concept design, business and operational planning, marketing and business development strategy, growth strategy, and due diligence across various industries such as pharma, biotech, healthcare delivery services, healthcare technology, medtech, financial services, and technology.

She holds an M.B.A in Decision Science and Operations Research from the American University of Beirut and a Doctor of Pharmacy degree from Saint Joseph University of Beirut.

Previously, Dr. Sleiman has held key positions including Founder & CEO at Capital Growth Advisors UAE, Head of Healthcare Business Division at Lootah Holding, and roles at Multiply Group, Frost & Sullivan, InfoPro sal, American University of Beirut, NORTHERN IRELAND CO-OPERATION OVERSEAS, Novartis, and American Life Insurance Company.